NCT04360629View on ClinicalTrials.gov

Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer

NACompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

June 3, 2020

Primary Completion Date

December 30, 2021

Study Completion Date

December 30, 2021

Conditions
Advanced Ovarian Cancer
Interventions
DRUG

Tranexamic Acid

Tranexamic Acid will be given through central vein

DRUG

normal saline

normal saline will be given through central vein

Trial Locations (1)

200040

Shanghai Cancer Center, Fudan University, Shanghai

All Listed Sponsors
lead

Jun Zhang

OTHER

NCT04360629 - Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer | Biotech Hunter | Biotech Hunter